Origen de la red de primer grado Kristin Henøen.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Regional Banks | 39 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Kristin Henøen a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
Bud Fræna og Hustad Sparebank
 Bud Fræna og Hustad Sparebank Major BanksFinance Bud Fræna og Hustad Sparebank operates as commercial bank. Its services include debits, eInvoice, savings, credit, senior account, loans for vehicles, consumer, mortgage, online banking, insurance, and SMS notification. The company was founded in 1883 and is headquartered in Elnesvågen, Norway. | Major Banks | Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| SUNNDAL SPAREBANK | Savings Banks | Director/Board Member | |
| Høgskolen i Molde | College/University | Graduate Degree | |
Vinje Ullvarefabrikk AS
 Vinje Ullvarefabrikk AS Apparel/FootwearConsumer Non-Durables Vinje Ullvarefabrikk AS specializes in producing woolen clothing made from 100%% merino wool that does not itch. The private company is based in Vinje, Norway. The Norwegian company prioritizes animal welfare and uses a unique knitting pattern that enhances the natural properties of the wool. The company's Lanullva line of clothing optimizes moisture transport and regulates body temperature, making it ideal for various indoor and outdoor activities throughout the year. | Apparel/Footwear | Director of Finance/CFO | |
Xpro AS
 Xpro AS Miscellaneous Commercial ServicesCommercial Services Part of AFRY AB, Xpro AS is a Norwegian company that is currently developing a next-generation selective inhibitor of tumor necrosis factor (TNF) called xpro™. The company is based in Molde, Norway. The drug is currently in clinical trials and has the potential to decrease neuroinflammation, neurodegeneration, and promote remyelination in patients with neurologic disease by neutralizing soluble TNF. The company was founded in 2016. The CEO is Vegard Storvik. | Miscellaneous Commercial Services | Chairman |
Estadísticas
Internacional
| Noruega | 7 |
Sectorial
| Finance | 3 |
| Process Industries | 2 |
| Consumer Services | 2 |
| Consumer Non-Durables | 2 |
| Commercial Services | 2 |
Operativa
| Director/Board Member | 38 |
| Chairman | 4 |
| Corporate Officer/Principal | 3 |
| Director of Finance/CFO | 3 |
| Chief Executive Officer | 2 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Kristin Henøen
- Conexiones Empresas
